WPRIM Management System> DCMS> Blood Research> 2019> 54> 4

Volume: 54 Issue: 4

1. Differential impact of anti-thymocyte globulin dosing by disease risk index in alternative donor peripheral blood stem cell transplantation in patients with acute leukemia or myelodysplastic syndrome after reduced intensity conditioning Page:290—295
2. Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation Page:288—290
3. Beta-2 microglobulin as a prognostic factor of primary central nervous system lymphoma Page:285—288
4. Retrospective screening for Philadelphia-negative myeloproliferative neoplasms in patients with cerebral infarctions as revealed using the revised 2016 World Health Organization diagnostic criteria Page:284—285
5. EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis Page:282—284
6. Clinical significance of T cell receptor excision circle (TREC) quantitation after allogenic HSCT Page:274—281
7. The increasing trend of blood donation in Iran Page:269—273
8. Evaluating the effect of donor anxiety levels and lifestyle characteristics on the activation of platelet concentrates Page:262—268
9. Potential biomarkers and antagonists for fluoranthene-induced cellular toxicity of bone marrow derived mesenchymal stem cells Page:253—261
10. Clinical impacts of inflammatory markers and clinical factors in patients with relapsed or refractory diffuse large B-cell lymphoma Page:244—252
11. Do not jump to hasty conclusions: all gamma delta T-cells neoplasms are not aggressive! Page:243—243
12. Recurred breast cancer presenting with autoimmune hemolytic anemia Page:242—242
13. Chronic lymphocytic leukemia with unusual cytoplasmic anomalies Page:241—241

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.